Decreased Carbonyl Reductase 1 Expression Promotes Tumor Growth Via Epithelial Mesenchymal Transition in Uterine Cervical Squamous Cell Carcinomas

Overview

Journal Reprod Med Biol

Specialty Biology

Date 2018 Apr 26

PMID 29692675

Citations 7

Authors

Yuki Nishimoto

Akihiro Murakami

Shun Sato

Takuya Kajimura

Kengo Nakashima

Kazuyuki Yakabe

Kotaro Sueoka

Norihiro Sugino

Affiliations

Soon will be listed here.

Abstract

Purpose: Carbonyl reductase 1 (CBR1) is involved in cancer progression. Recently, the authors reported that the loss of CBR1 expression is associated with a poor prognosis in uterine cervical cancer. Here, we investigated whether the decreased CBR1 expression promotes cancer progression by inducing the epithelial mesenchymal transition (EMT).

Methods: Antisense constructs of complementary DNA (antisense clones) and the empty vectors (control clones) were transfected into human uterine cervical squamous cell carcinoma cell lines (SKG II and SiHa) and the proliferation and EMT marker expression of these clones were analyzed in vitro. In an in vivo study, 10 cells of the antisense and control clones were subcutaneously injected into nude mice and the tumorigenesis was observed for 8 weeks.

Results: With the decreased CBR1 expression, the proliferation of the antisense clones increased, accompanied by a decrease in epithelial markers (E-cadherin and cytokeratin) and an increase in mesenchymal markers (fibronectin, alpha-smooth muscle actin, and N-cadherin), which suggests EMT induction. In the in vivo study, the tumor volume in the antisense group was significantly larger than that in the control group.

Conclusion: Decreased CBR1 expression promotes tumor growth by inducing EMT in uterine cervical squamous cell carcinomas.

Citing Articles

Establishment of a 3D spheroid culture system to evaluate the responsiveness of uterine leiomyoma cells to female hormones.

Sakai T, Sato S, Tamehisa T, Takasaki H, Kajimura T, Tamura I Reprod Med Biol. 2025; 24(1):e12627.

PMID: 39845479 PMC: 11751880. DOI: 10.1002/rmb2.12627.

Overexpression of carbonyl reductase 1 in ovarian cancer cells suppresses proliferation and activates the eIF2 signaling pathway.

Kadonosawa Y, Yokoyama M, Tatara Y, Fujita T, Yokoyama Y Oncol Lett. 2024; 28(2):359.

PMID: 38881711 PMC: 11177172. DOI: 10.3892/ol.2024.14492.

Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?.

Barillari G, Bei R, Manzari V, Modesti A Int J Mol Sci. 2021; 22(24).

PMID: 34948338 PMC: 8703928. DOI: 10.3390/ijms222413543.

Identification of aberrantly expressed long non-coding RNAs in ovarian high-grade serous carcinoma cells.

Nakashima K, Sato S, Tamura I, Hayashi-Okada M, Tamehisa T, Kajimura T Reprod Med Biol. 2020; 19(3):277-285.

PMID: 32684827 PMC: 7360959. DOI: 10.1002/rmb2.12330.

Overexpression of carbonyl reductase 1 inhibits malignant behaviors and epithelial mesenchymal transition by suppressing TGF-β signaling in uterine leiomyosarcoma cells.

Kajimura T, Sato S, Murakami A, Hayashi-Okada M, Nakashima K, Sueoka K Oncol Lett. 2019; 18(2):1503-1512.

PMID: 31423217 PMC: 6607169. DOI: 10.3892/ol.2019.10429.

References

Deckers M, van Dinther M, Buijs J, Que I, Lowik C, van der Pluijm G . The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res. 2006; 66(4):2202-9. DOI: 10.1158/0008-5472.CAN-05-3560. View

Yokoyama Y, Xin B, Shigeto T, Umemoto M, Kasai-Sakamoto A, Futagami M . Clofibric acid, a peroxisome proliferator-activated receptor alpha ligand, inhibits growth of human ovarian cancer. Mol Cancer Ther. 2007; 6(4):1379-86. DOI: 10.1158/1535-7163.MCT-06-0722. View

Maekawa R, Taketani T, Mihara Y, Sato S, Okada M, Tamura I . Thin endometrium transcriptome analysis reveals a potential mechanism of implantation failure. Reprod Med Biol. 2017; 16(2):206-227. PMC: 5661823. DOI: 10.1002/rmb2.12030. View

Zhang J, Mai S, Huang X, Wang F, Liao Y, Lin M . MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling. Ann Oncol. 2014; 25(11):2196-2204. DOI: 10.1093/annonc/mdu439. View

Nishimoto Y, Murakami A, Sato S, Kajimura T, Nakashima K, Yakabe K . Decreased carbonyl reductase 1 expression promotes tumor growth via epithelial mesenchymal transition in uterine cervical squamous cell carcinomas. Reprod Med Biol. 2018; 17(2):173-181. PMC: 5902461. DOI: 10.1002/rmb2.12086. View

Thiery J, Acloque H, Huang R, Nieto M . Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139(5):871-90. DOI: 10.1016/j.cell.2009.11.007. View

Liu Q, Chen K, Ye Q, Jiang X, Sun Y . Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway. Cancer Cell Int. 2016; 16:57. PMC: 4957915. DOI: 10.1186/s12935-016-0336-z. View

Zavadil J, Bottinger E . TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005; 24(37):5764-74. DOI: 10.1038/sj.onc.1208927. View

Bates R, Mercurio A . The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther. 2005; 4(4):365-70. DOI: 10.4161/cbt.4.4.1655. View

10.

Miura R, Yokoyama Y, Shigeto T, Futagami M, Mizunuma H . Inhibitory effect of carbonyl reductase 1 on ovarian cancer growth via tumor necrosis factor receptor signaling. Int J Oncol. 2015; 47(6):2173-80. DOI: 10.3892/ijo.2015.3205. View

11.

Umemoto M, Yokoyama Y, Sato S, Tsuchida S, Al-Mulla F, Saito Y . Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer. Br J Cancer. 2001; 85(7):1032-6. PMC: 2375107. DOI: 10.1054/bjoc.2001.2034. View

12.

Ahmed N, Abubaker K, Findlay J, Quinn M . Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr Cancer Drug Targets. 2010; 10(3):268-78. DOI: 10.2174/156800910791190175. View

13.

Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J . The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000; 2(2):84-9. DOI: 10.1038/35000034. View

14.

Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

15.

Yakabe K, Murakami A, Kajimura T, Nishimoto Y, Sueoka K, Sato S . Functional significance of transgelin-2 in uterine cervical squamous cell carcinoma. J Obstet Gynaecol Res. 2016; 42(5):566-72. DOI: 10.1111/jog.12935. View

16.

Penning T, Drury J . Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms. Arch Biochem Biophys. 2007; 464(2):241-50. PMC: 2025677. DOI: 10.1016/j.abb.2007.04.024. View

17.

Murakami A, Fukushima C, Yoshidomi K, Sueoka K, Nawata S, Yokoyama Y . Suppression of carbonyl reductase expression enhances malignant behaviour in uterine cervical squamous cell carcinoma: carbonyl reductase predicts prognosis and lymph node metastasis. Cancer Lett. 2011; 311(1):77-84. DOI: 10.1016/j.canlet.2011.06.036. View

18.

Wermuth B, Bohren K, Heinemann G, VON WARTBURG J, GABBAY K . Human carbonyl reductase. Nucleotide sequence analysis of a cDNA and amino acid sequence of the encoded protein. J Biol Chem. 1988; 263(31):16185-8. View

19.

Gu Y, Wang Q, Guo K, Qin W, Liao W, Wang S . TUSC3 promotes colorectal cancer progression and epithelial-mesenchymal transition (EMT) through WNT/β-catenin and MAPK signalling. J Pathol. 2016; 239(1):60-71. DOI: 10.1002/path.4697. View

20.

Mindnich R, Penning T . Aldo-keto reductase (AKR) superfamily: genomics and annotation. Hum Genomics. 2009; 3(4):362-70. PMC: 3206293. DOI: 10.1186/1479-7364-3-4-362. View